Nurse Practitioner, Family · Beaumont, TX
NPI
1821527284
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1495 N 7th St
Beaumont, TX, 77702
Phone (409) 832-3377
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$4.0M
4,578 prescriptions
Company payments, 2025
$965
From 13 companies
Medicare prescription drug claims, 2024
In 2024, the drug Myeisha T Casmire Clifton prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 348 prescriptions and refills. In total Myeisha T Casmire Clifton wrote 4,578 Medicare prescriptions that cost $4.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 348 | 348 | 41 | $1.3M |
| Atorvastatin Calcium Generic | 316 | 547 | 71 | $1,488 |
| Amlodipine Besylate Generic | 260 | 462 | 58 | $865 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 191 | 205 | 26 | $940K |
| Gabapentin Generic | 138 | 222 | 38 | $1,815 |
| Losartan Potassium Generic | 126 | 234 | 34 | $618 |
| Lisinopril Generic | 119 | 206 | 28 | $486 |
| Metformin Hcl Generic | 99 | 169 | 23 | $382 |
| Descovy Emtricitabine/Tenofov Alafenam | 99 | 101 | 11 | $214K |
| Rosuvastatin Calcium Generic | 71 | 144 | 21 | $985 |
| Omeprazole Generic | 67 | 107 | 18 | $768 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 67 | 93 | 13 | $2,027 |
| Metoprolol Tartrate Generic | 65 | 109 | 11 | $194 |
| Ozempic Semaglutide | 65 | 97 | 14 | $79K |
| Synjardy Empagliflozin/Metformin Hcl | 65 | 102 | 12 | $59K |
Brand drugs: 1,559 claims; generic drugs: 2,984 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Myeisha T Casmire Clifton $965 ($965 in general payments such as food, travel and fees) from 13 companies. The largest payer was Gilead Sciences, Inc. with $316.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 17 | $316 |
| ViiV Healthcare Company GSK | 7 | $160 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $148 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $70.4 |
| Merck Sharp & Dohme LLC MRK | 3 | $69.52 |
| Novo Nordisk Inc NVO | 3 | $47.07 |
| Theratechnologies Inc. THTX | 1 | $34.39 |
| Napo Pharmaceuticals Inc | 1 | $24.84 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $22.33 |
| EMD Serono, Inc. MRK.DE | 1 | $21.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.